By:
On:
In: Good company, Stock analysis
Tagged:
With: 0 Comments
Company name Atlas Pipeline Partners, L.P.
Stock ticker APL
Live stock price [stckqut]APL[/stckqut]
P/E compared to competitors Good
MANAGEMENT EXECUTION
Employee productivity Good
Sales growth Good
EPS growth Good
P/E growth Good
EBIT growth Good
ANALYSIS
Confident Investor Rating Good
Target stock price (TWCA growth scenario) $45.49
Target stock price (averages with growth) $30.68
Target stock price (averages with no growth) $11.7
Target stock price (manual assumptions) $35.6

The following company description is from Google Finance: http://www.google.com/finance?q=apl

Atlas Pipeline Partners, L.P. (the Partnership) is a provider of natural gas gathering, processing and treating services in the Anadarko and Permian Basins located in the southwestern and mid-continent regions of the United States and a provider of natural gas gathering services in the Appalachian Basin in the northeastern region of the United States. The Company conducts its business in the midstream segment of the natural gas industry through two segments: Mid-Continent and Appalachia. The Partnership�s operations are conducted through subsidiary entities whose interests are owned by Atlas Pipeline Operating Partnership, L.P. (the Operating Partnership), a wholly owned subsidiary of the Partnership. Its partner, Atlas Pipeline Partners GP, LLC (the General Partner), manages its operations and activities through its ownership of its general partner interest.

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in this stock. There are few companies that show this much green after my analysis!

By:
On:
In: Good company, Stock analysis
Tagged:
With: 0 Comments
Company name ANSYS, Inc.
Stock ticker ANSS
Live stock price [stckqut]ANSS[/stckqut]
P/E compared to competitors Fair
MANAGEMENT EXECUTION
Employee productivity Good
Sales growth Good
EPS growth Good
P/E growth Good
EBIT growth Good
ANALYSIS
Confident Investor Rating Good
Target stock price (TWCA growth scenario) $81.19
Target stock price (averages with growth) $112.7
Target stock price (averages with no growth) $86.18
Target stock price (manual assumptions) $69.59

The following company description is from Google Finance: http://www.google.com/finance?q=anss

ANSYS, Inc. (ANSYS) develops and markets engineering simulation software and services used by engineers, designers, researchers and students across a range of industries and academia, including aerospace, automotive, manufacturing, electronics, biomedical, energy and defense. ANSYS focuses on the development of open and flexible solutions. The Company distributes its ANSYS suite of simulation technologies, through a global network of resellers and distributors (collectively, channel partners) and direct sales offices in global locations. The Company’s product portfolio consists of ANSYS Workbench, Multiphysics, Structural Mechanics, Fluid Dynamics, Explicit Dynamics, Electromagnetics, Simulation Process and Data Management, Academic, High-Performance Computing and Geometry Interfaces. In August 2011, the Company acquired Apache Design Solutions, Inc.

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in this stock.

By:
On:
In: Fair company, Stock analysis
Tagged:
With: 0 Comments
Company name Amazon.com, Inc.
Stock ticker AMZN
Live stock price [stckqut]AMZN[/stckqut]
P/E compared to competitors Fair
MANAGEMENT EXECUTION
Employee productivity Fair
Sales growth Good
EPS growth Good
P/E growth Poor
EBIT growth Good
ANALYSIS
Confident Investor Rating Fair
Target stock price (TWCA growth scenario) $326.18
Target stock price (averages with growth) $424.57
Target stock price (averages with no growth) $269.3
Target stock price (manual assumptions) $326.18

The following company description is from Google Finance: http://www.google.com/finance?q=amzn

Amazon.com, Inc. (Amazon.com) is a customer-centric company for three primary customer sets: consumers, sellers and enterprises. In addition, the Company generates revenue through other marketing and promotional services, such as online advertising, and co-branded credit card agreements. The Company operates in two segments: North America and International. The Company serves consumers through its retail Websites, and focus on selection, price, and convenience. It designs its Websites to enable products to be sold by it and by third parties across dozens of product categories. It also manufactures and sells the Kindle e-reader. It offers customers membership in Amazon Prime. It also provides easy-to-use functionality, fulfillment and customer service. In February 2010, the Company acquired Touchco, a touch screen technology company.

Confident Investor comments: At this time, I think that a Confident Investor can cautiously invest in this stock as long as the price is correct. Most of the fundamentals of this company are good but there are some concerns. Due to the growth expectations for this company, I am leaving it on my Watch List.

By:
On:
In: Good company, Stock analysis
Tagged:
With: 0 Comments
Company name Alexion Pharmaceuticals, Inc.
Stock ticker ALXN
Live stock price [stckqut]ALXN[/stckqut]
P/E compared to competitors Fair
MANAGEMENT EXECUTION
Employee productivity Good
Sales growth Good
EPS growth Good
P/E growth Good
EBIT growth Good
ANALYSIS
Confident Investor Rating Good
Target stock price (TWCA growth scenario) $88.56
Target stock price (averages with growth) $106.34
Target stock price (averages with no growth) $58.39
Target stock price (manual assumptions) $88.59

The following company description is from Google Finance: http://www.google.com/finance?q=alxn

Alexion Pharmaceuticals, Inc. (Alexion) is a biopharmaceutical company engaged in the discovery, development and commercialization of therapeutic products aimed at treating patients with severe and life-threatening disease states, including those in the therapeutic areas of hematology, nephrology (including transplant rejection), neurology, ophthalmology and cancer. Alexion’s marketed product, Soliris (eculizumab), is a therapy approved for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH). On January 28, 2011, Alexion acquired Taligen Therapeutics, Inc. (Taligen). On February 10, 2011, Alexion acquired patents and assets from Germany-based Orphatec Pharmaceuticals GmbH (Orphatec) related to an investigational therapy for patients with Type A molybdenum cofactor deficiency (MoCD).

Confident Investor comments: This company’s growth rate could actually dictate a much higher price than I am conservatively giving it. At this price and at this time, I think that a Confident Investor can confidently invest in this stock.

By:
On:
In: Good company, Stock analysis
Tagged:
With: 0 Comments
Company name Akamai Technologies, Inc.
Stock ticker AKAM
Live stock price [stckqut]AKAM[/stckqut]
P/E compared to competitors Good
MANAGEMENT EXECUTION
Employee productivity Poor
Sales growth Good
EPS growth Good
P/E growth Good
EBIT growth Fair
ANALYSIS
Confident Investor Rating Good
Target stock price (TWCA growth scenario) $33.98
Target stock price (averages with growth) $51.56
Target stock price (averages with no growth) $44.54
Target stock price (manual assumptions) $27.48

The following company description is from Google Finance: http://www.google.com/finance?q=akam

Akamai Technologies, Inc. (Akamai) provides services for accelerating and improving the delivery of content and applications over the Internet; ranging from live and on-demand streaming video capabilities to conventional content on Websites, to tools that help people transact business and reach out to new and existing customers. Its services are used to sell, inform, entertain, market, advertise, deliver software and conduct their business online. It offers application performance services, services and solutions for digital media and software distribution and storage, content and application delivery, online advertising-related services and other specialized Internet-based offerings. In July 2010, the Company completed the acquisition of Velocitude LLC (Velocitude).

Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in this stock.